Autonomix Ebit from 2010 to 2026

AMIX Stock   0.54  0.01  1.82%   
Autonomix Medical EBIT yearly trend continues to be fairly stable with very little volatility. EBIT will likely drop to about -10.6 M in 2026. During the period from 2010 to 2026, Autonomix Medical EBIT regression line of annual values had significance of  0.15 and arithmetic mean of (12,081,579). View All Fundamentals
 
EBIT  
First Reported
2010-12-31
Previous Quarter
-10.1 M
Current Value
-10.6 M
Quarterly Volatility
2.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Autonomix Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Autonomix Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 156.5 K, Interest Expense of 94.6 K or Selling General Administrative of 5.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.42. Autonomix financial statements analysis is a perfect complement when working with Autonomix Medical Valuation or Volatility modules.
  
Build AI portfolio with Autonomix Stock
Check out the analysis of Autonomix Medical Correlation against competitors.

Latest Autonomix Medical's Ebit Growth Pattern

Below is the plot of the Ebit of Autonomix Medical Common over the last few years. It is Autonomix Medical's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Autonomix Medical's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

Autonomix Ebit Regression Statistics

Arithmetic Mean(12,081,579)
Coefficient Of Variation(19.63)
Mean Deviation1,457,071
Median(12,841,553)
Standard Deviation2,371,342
Sample Variance5.6T
Range11.4M
R-Value0.36
Mean Square Error5.2T
R-Squared0.13
Significance0.15
Slope170,300
Total Sum of Squares90T

Autonomix Ebit History

2026-10.6 M
2025-10.1 M
2024-11.2 M
2023-15.3 M
2022-4 M

Other Fundumenentals of Autonomix Medical Common

About Autonomix Medical Financial Statements

Autonomix Medical investors use historical fundamental indicators, such as Autonomix Medical's Ebit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Autonomix Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBIT-10.1 M-10.6 M
EBITDA-9.9 M-10.4 M
Ebt Per Ebit 0.89  1.07 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Autonomix Stock Analysis

When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.